Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients | BioSpace

[ad_1]   SHANGHAI, Sept. 25, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services for patients with cancer…

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management | BioSpace

[ad_1] SHANGHAI, Aug. 24, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services for patients with cancer and other major diseases,…